We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current THRL market cap is 527.2M. The company's latest EPS is GBP 0.1177 and P/E is 7.22.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 44.27M | 49.98M | 63.86M | 67.75M | 69.55M |
| Operating Income | 34.7M | 45.73M | 61.57M | 60.69M | 67.7M |
| Net Income | 31.62M | 43.88M | 49.1M | -6.57M | 73.02M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 663.77M | 718.39M | 963.66M | 908.26M | 967.37M |
| Total Liabilities | 169.66M | 153.21M | 264.89M | 253.45M | 278.08M |
| Total Equity | 494.11M | 565.19M | 698.77M | 654.81M | 689.29M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 21.47M | 24.96M | 30.39M | 29.67M | 42.35M |
| Investing | -103.42M | -43.58M | -202.63M | -3.55M | 3.42M |
| Financing | 91.44M | 3.29M | 185.62M | -45.23M | -22.24M |
| Market Cap | 527.2M |
| Price to Earnings Ratio | 7.22 |
| Price to Sales Ratio | 7.58 |
| Price to Cash Ratio | 13.56 |
| Price to Book Ratio | 0.76 |
| Dividend Yield | 6.92% |
| Shares Outstanding | 620.24M |
| Average Volume (1 week) | 995.13k |
| Average Volume (1 Month) | 996.65k |
| 52 Week Change | -2.19% |
| 52 Week High | 93.00 |
| 52 Week Low | 75.00 |
| Spread (Intraday) | 0.4 (0.47%) |
| Company Name | Target Healthcare Reit Plc |
| Address |
level 13 broadgate tower london EC2A 2EW |
| Website | https://www.targethealthcarereit.co.uk |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
